Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-02-01

Clinical Trial Update: Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy [NA]

View source ↗

Summary

A Roswell Park Cancer Institute study evaluating a combination of ketoconazole, dexamethasone, and hydrocortisone for patients with prostate cancer that did not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • HYDROCORTISONE (HYDROCORTISONE)
  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Cancer | NA | Status: WITHDRAWN